Target intelligence / Profile preview

Troponin T, slow skeletal muscle (TNNT1)

Target
TNNT1
Molecular classification
Other, Sarcomeric thin filament protein, component of the troponin complex
01

Overview

Troponin T, slow skeletal muscle (TNNT1) is a subunit of the troponin complex specifically expressed in the sarcomeres of slow-twitch skeletal muscle fibers[1][3]. It plays a crucial structural and regulatory role by anchoring the troponin complex to tropomyosin and the actin filament, thereby enabling calcium-regulated muscle contraction. Mutations in the TNNT1 gene disrupt the assembly or function of the troponin complex, abolishing proper muscle contraction, and cause severe, recessively inherited nemaline myopathy—most notably Amish nemaline myopathy (ANM)—which manifests as profound muscle weakness, atrophy of type I muscle fibers, and is often fatal in early infancy. TNNT1 is not considered a typical therapeutic target like receptors or enzymes, but its essential role in muscle physiology makes it a critical protein in skeletal muscle biology[1][2][3][4].

Other names
Slow skeletal muscle troponin TTnTssTnTAmish nemaline myopathy proteinANMSTNTTNTTNTSNEM5troponin T1slow skeletalnemaline myopathy type 5troponin T type 1 (skeletal, slow)troponin-T1skeletal, slowFLJ98147MGC104241
02

Biological functions

Muscle contraction regulationTropomyosin bindingSarcomere thin filament anchoringModulation of muscle type contractility
03

Disease associations

OtherInherited myopathyspecifically recessive nemaline myopathy and Amish nemaline myopathy
04

Safety considerations

No known therapeutic targeting; mutations cause severe, lethal myopathic phenotypes such as muscle weakness and fatal muscle atrophy in infants[1][2][3]
05

Biomarkers

Possible use of muscle TNNT1 mutations or deficiency as a biomarker for nemaline myopathy diagnosis

Beyond the preview

Go deeper on Troponin T, slow skeletal muscle (TNNT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Troponin T, slow skeletal muscle (TNNT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call